Ensysce Biosciences
ENSC
9 hedge funds and large institutions have $903K invested in Ensysce Biosciences in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
14.3% more ownership
Funds ownership: 10.75% → 25.05% (+14%)
13% more funds holding
Funds holding: 8 → 9 (+1)
21% less capital invested
Capital invested by funds: $1.15M → $903K (-$242K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$811K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$272K |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$143K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.13K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$17 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$423 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
M
1
Murchinson
Toronto,
Ontario, Canada
| $358K | +$811K | +140,000 | New |
|
|
PA
2
Perceptive Advisors
New York
| $222K | – | – | – |
|
|
3
Adage Capital Partners
Boston,
Massachusetts
| $191K | +$143K | +24,711 | +49% |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| $120K | +$272K | +46,954 | New |
|
|
FIA
5
FNY Investment Advisers
New York
| $7K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $3.35K | +$4.13K | +713 | +120% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $1.13K | +$17 | +3 | +0.7% |
|
8
BlackRock
New York
| $166 | +$6 | +1 | +2% |
|
9
Bank of America
Charlotte,
North Carolina
| $20 | – | – | – |
|
|
10
Morgan Stanley
New York
| – | -$423 | -52 | Closed |
|
ENSC Hedge Fund Activity: Q1 2025 in Review
9 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Ensysce Biosciences (ENSC) for Q1 2025, worth a combined $903K — down 21% from $1.15M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ENSC positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Murchinson, opening a new position worth an estimated $811K. The largest seller was Morgan Stanley, exiting entirely with an estimated $423 sold.
- 9 institutional investors held Ensysce Biosciences (ENSC) as of Q1 2025, up from 8 in Q4 2024.
- Funds reported $903K of Ensysce Biosciences stock for Q1 2025, down 21% quarter-over-quarter.
- 2 funds opened new Ensysce Biosciences positions in Q1 2025 and 1 closed out, a net change of +1 holder.
- The largest Ensysce Biosciences buyer in Q1 2025 was Murchinson, an estimated $811K added.
- The largest Ensysce Biosciences seller in Q1 2025 was Morgan Stanley, an estimated $423 sold.
Based on aggregated 13F filings for Q1 2025.